These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1889635)

  • 1. Chirality and its importance in drug development.
    Campbell DB; Wilson K
    Biochem Soc Trans; 1991 Apr; 19(2):472-5. PubMed ID: 1889635
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlling chirality in enzymatic synthesis.
    Hodgson J
    Biotechnology (N Y); 1992 Oct; 10(10):1093-7. PubMed ID: 1368788
    [No Abstract]   [Full Text] [Related]  

  • 3. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chirality and its importance in drug development: an analytical chemist's perspective.
    Fell AF; Ley GW
    Biochem Soc Trans; 1991 Apr; 19(2):454-6. PubMed ID: 1889628
    [No Abstract]   [Full Text] [Related]  

  • 5. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 7. Chirality and its importance in drug development: a synthetic chemist's perspective.
    Roberts SM
    Biochem Soc Trans; 1991 Apr; 19(2):446-53. PubMed ID: 1889627
    [No Abstract]   [Full Text] [Related]  

  • 8. A patent lawyer's perspective.
    White AW
    Biochem Soc Trans; 1991 Apr; 19(2):469-72. PubMed ID: 1889634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory implications: a company's perspective.
    Macdonald CM
    Biochem Soc Trans; 1991 Apr; 19(2):467-8. PubMed ID: 1889633
    [No Abstract]   [Full Text] [Related]  

  • 10. High-throughput and parallel screening methods in asymmetric hydrogenation.
    Jäkel C; Paciello R
    Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic approaches to the 2007 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Li J
    Mini Rev Med Chem; 2008 Dec; 8(14):1526-48. PubMed ID: 19075810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chirality in new drug development. Clinical pharmacokinetic considerations.
    Nation RL
    Clin Pharmacokinet; 1994 Oct; 27(4):249-55. PubMed ID: 7834962
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective use of preparative chiral HPLC in a preclinical drug synthesis.
    Nelson TD; Welch CJ; Rosen JD; Smitrovich JH; Huffman MA; McNamara JM; Mathre DJ
    Chirality; 2004 Nov; 16(9):609-13. PubMed ID: 15390084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational and efficient geometric definition of pharmacophores is essential for the patent process.
    Guérin GA; Pratuangdejkul J; Alemany M; Launay JM; Manivet P
    Drug Discov Today; 2006 Nov; 11(21-22):991-8. PubMed ID: 17055408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chirality--a new era of therapeutics.
    Agrawal YK; Bhatt HG; Raval HG; Oza PM; Gogoi PJ
    Mini Rev Med Chem; 2007 May; 7(5):451-60. PubMed ID: 17504180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of methyl in drug design].
    Lian J; Wang J; Sun HF; Lin DZ; Liu H
    Yao Xue Xue Bao; 2013 Aug; 48(8):1195-208. PubMed ID: 24187825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approach to a novel axially chiral ligand showing spontaneous enrichment of axial chirality.
    Hasegawa T; Omote M; Sato K; Ando A; Kumadaki I
    Chem Pharm Bull (Tokyo); 2003 Mar; 51(3):265-7. PubMed ID: 12612409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chirality and drugs in clinical practice and its ethical aspect.
    Banerjee M; Biswas I; Halder S
    J Indian Med Assoc; 2009 Jan; 107(1):41-2. PubMed ID: 19588688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chirality and its importance in drug development: what are the issues?
    Beckett AH
    Biochem Soc Trans; 1991 Apr; 19(2):443-6. PubMed ID: 1889626
    [No Abstract]   [Full Text] [Related]  

  • 20. Asymmetric synthesis of active pharmaceutical ingredients.
    Farina V; Reeves JT; Senanayake CH; Song JJ
    Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.